$2M virtual reality trial to gauge impact on senior living residents with dementia
By
Alicia Lasek
Aug 20, 2021
The Phase II trial will evaluate how virtual family engagement affects quality of life for 400 older adults in 12 U.S. long-term care communities.
National survey tells story of COVID in assisted living
By
Alicia Lasek
Aug 19, 2021
New industry data from the CDC’s National Center for Health Statistics details how COVID-19 affected assisted living communities across the country during the height of the pandemic.
Feds tell nursing homes to use vaccinated staff or lose funding: Providers cry foul
By
Danielle Brown
Aug 19, 2021
President Joe Biden announced late Wednesday afternoon that U.S. nursing homes must use workers vaccinated against COVID-19 or risk losing vital Medicare and Medicaid funding. Providers immediately criticized...
VA will not add Alzheimer’s drug Aduhelm to its formulary
By
Alicia Lasek
Aug 12, 2021
The Department of Veterans Affairs has chosen not to include aducanumab (Aduhelm) in its national list of covered drugs, citing risk of adverse events and lack of evidence of positive impact on cognition,...
New cases of antifungal-resistant yeast infections in nursing homes alarm CDC
By
Alicia Lasek
Jul 26, 2021
For the first time, the Centers of Disease Control and Prevention has identified U.S. nursing home residents and hospital patients with candida auris yeast infections that resist all first-line antifungal...
Slow buy-in: Only 3% of neurologists have written Aduhelm prescriptions so far
By
Alicia Lasek
Jul 15, 2021
Neurologists are very aware of Biogen’s newly approved Alzheimer’s drug, but few have prescribed it so far, a real-time study of the brand’s market launch has found.
Dementia diagnostics more accurate when patients recall Cinderella story
By
Alicia Lasek
Jul 15, 2021
Narrating an overlearned story, such as the Cinderella fairy tale, gave the most accurate results, identifying Alzheimer’s or mild cognitive impairment with 78% accuracy, investigators say.
FDA calls for investigation into its approval of controversial Alzheimer’s drug
By
Alicia Lasek
Jul 12, 2021
The acting chief of the Food and Drug Administration has called for an investigation into the events leading up to the approval of Biogen’s brain plaque-clearing dementia drug aducanumab (Aduhelm).
Clinical briefs for Monday, July 12
By
Alicia Lasek
Jul 12, 2021
Judge rejects claim that Zostavax caused man’s shingles eight years later … Get blood sugar under control early in type 2 diabetes to cut odds of these poor outcomes: experts … Arthritis drug reduces...
Diaries of infection preventionists offer peek into pandemic struggles
By
Alicia Lasek
Jul 06, 2021
Real-time reports from the height of the pandemic offer a glimpse into the highs and lows infection preventionists faced as they tackled unprecedented challenges.